Senior Director, Communications
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
In a new article for the CTC Sentinel, NTI | bio Vice President Jaime Yassif explains how advances in bioscience and biotechnology are accompanied by emerging biological risks and cites the need for action to safeguard the life sciences to prevent biotechnology catastrophe.
NTI | bio and the World Economic Forum (WEF) convened the third annual meeting of the Technical Consortium on DNA Synthesis Screening on May 12-13, 2022.
In a new perspective penned for Science and Diplomacy, NTI | bio’s Margaret Hamburg, Jaime Yassif, Hayley Severance and former NTI David A. Hamburg Distinguished Fellow R. Alta Charo highlight the increasing risks of accidental or deliberate misuse of modern bioscience and biotechnology, and propose the establishment of a new organization.
Sign up for our newsletter to get the latest on nuclear and biological threats.
NTI experts bring years of experience at the highest levels of government and research to tackle nuclear, chemical, biological and radiological threats.